Article
Putting Evidence Into Practice: Evidence-Based Interventions for Cancer and Cancer Treatment-Related Cognitive Impairment
Cognitive impairment is a clinically complex symptom commonly experienced by cancer survivors. Although research in this area has grown, many questions remain regarding underlying mechanisms, trajectory, and specific interventions nurses can offer patients to prevent, treat, and manage cognitive impairment effectively. As part of the Oncology Nursing Society (ONS) Putting Evidence Into Practice (PEP) initiative, a comprehensive examination of the current literature was conducted to identify effective interventions for cognitive impairment in cancer survivors. The studies were categorized into nonpharmacologic interventions, including complementary and alternative therapies and cognitive training, and pharmacologic interventions, including psychostimulants and erythropoietin-stimulating agents. Using the ONS PEP Weight of Evidence Classification Schema, the levels of evidence for these interventions were consistent with the categories of effectiveness not established or not recommended for practice. Additional research is needed to identify effective preventive and treatment strategies for cognitive impairment in cancer survivors.
Jump to a section
References
Ahles, T. A., & Saykin, A. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation, 19, 812-820. doi:10.1081/CNV-100107743
Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews. Cancer, 7, 192-201. doi:10.1038/nrc2073
Allen, D., Von Ah, D., Jansen, C., Schiavone, R., Gagnon, P., Wulff, J., & Behrendt, R. (2011). Cognitive impairment. In L. H. Eaton, J. M. Tipton, & M. Irwin (Eds.), Putting Evidence Into Practice: Improving patient outcomes (Vol. 2, pp. 15-30). Pittsburgh, PA: Oncology Nursing Society.
Berger, A. M., Barsevick, A., Bender, C. M., Cochrane, B., Duggleby, W. D., Friese, C. R., … Mallory, G. (2009). The 2009-2013 Research Agenda for oncology nursing [Online exclusive]. Oncology Nursing Forum, 36, E274-E282. doi:10.1188/09.ONF.E274-E282
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA, 297, 842-857. doi:10.1001/jama.297.8.842
Blackhall, L., Petroni, G., Shu, J., Baum, L., & Farace, E. (2009). A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. Journal of Palliative Medicine, 12, 433-439. doi:10.1089/jpm.2008.0230
Bruera, E., Miller, M. J., Macmillan, K., & Kuehn, N. (1992). Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain, 48, 163-166. doi:10.1016/0304-3959(92)90053-E
Butler, J. M., Jr., Case, L. D., Atkins, J., Frizzell, B., Sanders, G., Griffin, P., … Shaw, E. G. (2007). A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCI in brain tumor patients receiving radiation therapy. International Journal of Radiation Oncology, Biology, and Physics, 69, 1496-1501. doi:10.1016/j.ijrobp.2007.05.076
Calvio, L., Peugeot, M., Bruns, G. L., Todd, B. L., & Feuerstein, M. (2010). Measures of cognitive function and work in occupationally active breast cancer survivors. Journal of Occupational and Environmental Medicine, 52, 219-227. doi:10.1097/JOM.0b013e3181d0bef7
Centers for Disease Control and Prevention. (2011). Physical activity and health. Retrieved from http://www.cdc.gov/physicalactivity/everyone/health/index.html
Chan, A. S., Cheung, M. C., Law, S. C., & Chan, J. H. (2004). Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer, 100, 398-401. doi:10.1002/cncr.11885
Chang, J., Couture, F. A., Young, S. D., Lau, C. Y., & Lee McWatters, K. (2004). Weekly administration of epoetin alfa improves cognition and quality of life in patients with breast cancer receiving chemotherapy. Supportive Cancer Therapy, 2(1), 52-58. doi:10.3816/SCT.2004.n.023
Ciliska, D., Cullum, N., & Marks, S. (2001). Evaluation of systematic reviews of treatment and prevention interventions. Evidenced-Based Nursing, 4(4), 100-104.
Cimprich, B. (1993). Development of an intervention to restore attention in cancer patients. Cancer Nursing, 16, 83-92. doi:10.1097/00002820-199304000-00001
Cimprich, B., & Ronis, D. L. (2003). An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nursing, 26, 284-292. doi:10.1097/00002820-200308000-00005
Cull, A., Hay, C., Love, S. B., Mackie, M., Smets, E., & Stewart, M. (1996). What do cancer patients mean when they complain of concentration and memory problems? British Journal of Cancer, 74, 1674-1679. doi:10.1038/bjc.1996.608
Damron, B. H., Brant, J. M., Belansky, H. B., Friend, P. J., Samsonow, S., & Schaal, A. (2009). Putting Evidence Into Practice: Prevention and management of bleeding in patients with cancer. Clinical Journal of Oncology Nursing, 13, 573-583. doi:10.1188/09.CJON.573-583
Dietrich, J., Han, R., Yang, Y., Mayer-Pröschel, M., & Noble, M. (2006). CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology, 5, 22.
Ferguson, R. J., Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., & Mott, L. A. (2007). Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-Oncology, 16, 772-777. doi:10.1002/pon.1133
Fitch, M. I., Armstrong, J., & Tsang, S. (2008). Patients' experiences with cognitive changes after chemotherapy. Canadian Oncology Nursing Journal, 18(4), 180-192.
Gagnon, B., Low, G., & Schreier, G. (2005). Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: A prospective clinical study. Journal of Psychiatry and Neuroscience, 30(2), 100-107.
Gehring, K., Sitskoorn, M. M., Gundy, C. M., Sikkes, S. A., Klein, M., Postma, T. J., … Aaronson, N. K. (2009). Cognitive rehabilitation in patients with glioma: A randomized, controlled trial. Journal of Clinical Oncology, 27, 3712-3722. doi:10.1200/JCO.2008.20.5765
Hadorn, D. C., Baker, D., Hodges, J. S., & Hicks, N. (1996). Rating the quality of evidence for clinical practice guidelines. Journal of Clinical Epidemiology, 49, 749-754. doi:10.1016/0895-4356(96)00019-4
Hede, K. (2008). Chemobrain is real but may need new name. Journal of the National Cancer Institute, 100, 162-169. doi:10.1093/jnci/djn007
Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study. Cancer, 109, 1905-1913. doi:10.1002/cncr.22610
Hess, L. M., & Insel, K. C. (2007). Chemotherapy-related change in cognitive function: A conceptual model. Oncology Nursing Forum, 34, 981-994. doi:10.1188/07.ONF.981-994
Hewitt, M., Greenfield, S., & Stovall, E. (Eds.). (2005). From cancer patient to cancer survivor: Lost in transistion. Washington, DC: National Academies Press.
Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., … Holland, J. (2006). Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: A pilot prospective longitudinal study. Journal of the American Geriatrics Society, 54, 926-931.
Iconomou, G., Koutras, A., Karaivazoglou, K., Kalliolas, G. D., Assimakopoulos, K., Argyriou, A. A., … Kalofonos, H. P. (2008). Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy. European Journal of Cancer Care, 17, 535-541.
Jansen, C. (2010). Cognitive changes. In J. Eggert (Ed.), Cancer basics (pp. 361-369). Pittsburgh, PA: Oncology Nursing Society.
Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncology Nursing Forum, 32, 1151-1163. doi:10.1188/05.ONF.1151-1163
Jansen, C. E., Cooper, B. A., Dodd, M. J., & Miaskowski, C. A. (2011). A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Supportive Care in Cancer, 19, 1647-1656. doi:10.1007/s00520-010-0997-4
Jatoi, A., Kahanic, S. P., Frytak, S., Schaefer, P., Foote, R. L., Sloan, J., & Petersen, R. C. (2005). Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: Preliminary results and suggestions for future study designs. Supportive Care in Cancer, 13, 66-69. doi:10.1007/s00520-004-0696-0
Kaplan, R. (2001). The nature of the view from home: Psychological benefits. Environmental Behavior, 33, 507-542.
Kohli, S., Fisher, S. G., Tra, Y., Adams, M. J., Mapstone, M. E., Wesnes, K. A., … Morrow, G. R. (2009). The effects of modafinil on cognitive function in breast cancer survivors. Cancer, 115, 2605-2616. doi:10.1002/cncr.24287
Korstjens, I., Mesters, I., van der Peet, E., Gijsen, B., & van den Borne, B. (2006). Quality of life of cancer survivors after physical and psychosocial rehabilitation. European Journal of Cancer Prevention, 15, 541-547. doi:10.1097/01.cej.0000220625.77857.95
Kuo, F. E., & Sullivan, W. C. (2001). Aggression and violence in the inner city: Effects of environment via mental fatigue. Environmental Behavior, 33, 543-571. doi:10.1177/00139160121973124
Lezak, M. D., Howieson, D. B., & Loring D. W. (2004). Neuropsychological assessment (4th ed.). New York, NY: Oxford University Press.
Locke, D. E., Cerhan, J. H., Wu, W., Malec, J. F., Clark, M. M., Rummans, T. A., & Brown, P. D. (2008). Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: A pilot study. Journal of Supportive Oncology, 6, 383-391.
Lower, E. E., Fleishman, S., Cooper, A., Zeldis, J., Faleck, H., Yu, Z., & Manning, D. (2009). Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial. Journal of Pain and Symptom Management, 38, 650-662. doi:10.1016/j.jpainsymman.2009.03.011
Lundorff, L. E., Jønsson, B. H., & Sjøgren, P. (2009). Modafinil for attentional and psychomotor dysfunction in advanced cancer: A double-blind randomised, cross-over trial. Palliative Medicine, 23, 731-738. doi:10.1177/0269216309106872
Mancuso, A., Migliorino, M., De Santis, S., Saponiero, A., & De Marinis, F. (2006). Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of Oncology, 17, 146-150. doi:10.1093/annonc/mdj038
Mar Fan, H. G., Clemons, M., Xu, W., Chemerynsky, I., Breunis, H., Braganza, S., & Tannock, I. F. (2008). A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Supportive Care in Cancer, 16, 577-583. doi:10.1007/s00520-007-0341-9
Mar Fan, H. G., Park, A., Xu, W., Yi, Q. L., Braganza, S., Chang, J., … Tannock, I. F. (2009). The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psycho-Oncology, 18, 156-161.
Massa, E., Madeddu, C., Lusso, M. R., Gramignano, G., & Mantovani, G. (2006). Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Critical Reviews in Oncology/Hematology, 57, 175-182.
McDougall, G. J., Jr. (2001). Memory improvement program for elderly cancer survivors. Geriatric Nursing, 22, 185-190.
Mehnert, A., Scherwath, A., Schirmer, L., Schleimer, B., Petersen, C., Schulz-Kindermann, F., … Koch, U. (2007). The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Education and Counseling, 66, 108-118.
Melnyk, B. M., & Fineout-Overholt, E. (2010). Evidence-based practice in nursing and healthcare: A guide to best practice (2nd ed.). Philadelphia, PA: Lippincott Williams and Wilkins.
Meyers, C. A., Albitar, M., & Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104, 788-793. doi:10.1002/cncr.21234
Meyers, C. A., Byrne, K. S., & Komaki, R. (1995). Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer, 12, 231-235. doi:10.1016/0169-5002(95)00446-8
Meyers, C. A., & Wefel, J. S. (2003). The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: No ifs, ands, buts, or sensitivity. Journal of Clinical Oncology, 21, 3557-3558.
Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998). Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. Journal of Clinical Oncology, 16, 2522-2527. doi:10.1200/JCO.2003.07.080
Miller, E. R., III, Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005). Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Annals of Internal Medicine, 142, 37-46.
Mitchell, S. A., & Friese, C. R. (2010). ONS PEP (Putting Evidence Into Practice) Weight of Evidence Classification Schema decision rules for summative evaluation of a body of evidence. Retrieved from http://www.ons.org/Research/media/ons/docs/research/outcomes/weight-of-evidence-table.pdf
Munir, F., Burrows, J., Yarker, J., Kalawsky, K., & Bains, M. (2010). Women's perceptions of chemotherapy-induced cognitive side affects on work ability: A focus group study. Journal of Clinical Nursing, 19(9-10), 1362-1370.
O'Shaughnessy, J. A. (2002). Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. Clinical Breast Cancer Supplement, 3(Suppl. 3), S116-S120.
O'Shaughnessy, J. A., Vukelja, S. J., Holmes, F. A., Savin, M., Jones, M. Royall, D., … Von Hoff, D. (2005). Feasibility of quantifying the effects of epoetin alpha therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clinical Breast Cancer, 5, 439-446.
Poppelreuter, M., Weis, J., & Bartsch, H. H. (2009). Effects of specific neuropyschological training programs for breast cancer patients after adjuvant chemotherapy. Journal of Psychosocial Oncology, 27, 274-296. doi:10.1080/07347330902776044
Reid-Arndt, S. A. (2006). The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. Neurorehabilitation, 21, 51-64.
Ropka, M. E., & Spencer-Cisek, P. (2001). PRISM: Priority Symptom Management project phase I: Assessment. Oncology Nursing Forum, 28, 1585-1594.
Rutledge, D. N., DePalma, J. A., & Cunningham, M. (2004). A process model for evidence-based literature syntheses. Oncology Nursing Forum, 31, 543-550. doi:10.1188/04.ONF.543-550
Schwartz, A. L., Thompson, J. A., & Masood, N. (2002). Interferon-induced fatigue in patients with melanoma: A pilot study of exercise and methylphenidate [Online exclusive]. Oncology Nursing Forum, 29, E85-E90. doi:10.1188/02.ONF.E85-E90
Shaw, E. G., Rosdhal, R., D'Agostino, R. B., Jr., Lovato, J., Naughton, M. J., Robbins, M. E., & Rapp, S. R. (2006). Phase II study of done-pezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. Journal of Clinical Oncology, 24, 1415-1420. doi:10.1200/JCO.2005.03.3001
Sherer, M., Meyers, C. A., & Bergloff, P. (1997). Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer, 80, 250-257. doi:10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.0.CO;2-T
Sitzer, D. I., Twamley, E. W., & Jeste, D. V. (2006). Cognitive training in Alzheimer's disease: A meta-analysis of the literature. Acta Psychiatrica Scandinavica, 114, 75-90. doi:10.1111/j.16000447.2006.00789.x
Tennessen, C. M., & Cimprich, B. (1995). Views to nature: Effects on attention. Journal of Environmental Psychology, 15, 77-85.
Tucha, O., Smely, C., Preier, M., & Lange, K. W. (2000). Cognitive deficits before treatment among patients with brain tumors. Neurosurgery, 47, 324-333. doi:10.1097/00006123-200008000-00011
U. S. Department of Health and Human Services. (2004). Living beyond cancer: Finding a new balance. President's Cancer Panel 2003 annual report. Retrieved from http://cissecure.nci.nih.gov/ncipubs/detail.aspx?prodid=P986
U. S. Food and Drug Administration. (2010). FDA drug safety communication: Erythropoiesis-stimulating agents (ESAs): Procrit, Epogen and Aranesp. Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200297.htm
Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008). Cancer and cancer therapy-related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623-629. doi:10.1093/annonc/mdm500
Vardy, J., Wong, K., Yi, Q. L., Park, A., Maruff, P., Wagner, L., & Tannock, I. F. (2006). Assessing cognitive function in cancer patients. Supportive Care in Cancer, 14, 1111-1118. doi:10.1007/s00520-006-0037-6
Von Ah, D., Russell, K. M., Storniolo, A. M., & Carpenter, J. S. (2009). Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncology Nursing Forum, 36, 326-334. doi:10.1188/09.ONF.326-334
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer, 100, 2292-2299.
Wefel, J. S., Vidrine, D. J., Veramonti, T. L., Meyers, C. A., Marani, S. K., Hoekstra, H. J., … Gritz, E. R. (2011). Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer, 117, 190-196. doi:10.1002/cncr.25298